β-amyloid protein precursor expression in lacrimal glands and tear fluid

Investigative Ophthalmology and Visual Science

Volumn 37, Issue 13, 1996, Pages 2585-2593

  Van Setten, Gysbert B ^a   Nilsson, Lars ^b   Hahne, Solveig ^c   Johnston, Janet A ^b   Kvanta, Anders ^a   Gandy, Samuel E ^d   Näslund, Jan ^c   Nordstedt, Christer ^c  

^a ST ERIK S EYE HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Alzheimer's disease; amyloid; precursor; protease; secretion

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; CORNEA INJURY; HUMAN; HUMAN CELL; HUMAN TISSUE; LACRIMATION; NORMAL HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN ISOLATION; WOUND HEALING;

EID: 0030444847     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Yamada KM. Cell surface interactions with extracellular materials. Ann Rev Biorhem. 1983; 52:761-799.
2. Suda T, Nishida T, Ohashi Y, Nakagawa S, Manabe R. Fibronectin appears at the site of corneal stromal wound in rabbits. Curr Eye Res. 1982; 1:553-557.
3. Nishida T, Nakagawa S, Ohashi Y, Awata T, Manabe R. Fibronectin in corneal wound healing: Appearance in cultured rabbit cornea. Jpn J Ophthalmol 1982; 26:410-415.
4. Fujikawa LS, Foster CS, Gipson JK, Colvin RB. Basement membrane components in healing rabbit corneal epithelial wounds: Immunofluorescence and ultrastructural studies. J Cell Biol. 1984; 98:128-138.
5. Tervo T, Sulonen J, Valtonen S, Vannas A, Virtanen I. Distribution of fibronectin in human and rabbit corneas. Exp Eye Res. 1986; 42:399-406.
6. Tervo T, van Setten G-B. Aprotinin for inhibition of plasmin on the ocular surface: Principles and clinical observations. In: Beuermann RW, Crosson CE, Kaufman HE, eds. Healing Processes of the Cornea. The Woodlands, TX: Portfolio Publishing; 1989:151-160.
7. Takahashi K. The origin of fibronectin in healing corneal epithelial wounds evaluated by immunoelectron microscopy. Acta Soc Ophthalmol Jpn. 1987; 91:1164-1175.
8. Fukuda M, Yagi J, Yasumoto K, Mishima H, Nishida T, Otori T. Localization of fibronectin and actin in cultured rabbit keratocytes. Jpn J Ophthalmol. 1988; 32:16-21.
9. Cameron JD, Hagen ST, Waterfield RR, Furcht LT. Effects of matrix proteins on rabbit corneal epithelial cell adhesion and migration. Curr Eye Res. 1988; 7:293-301.
10. Vaheri A, Salonen E-M, Vartio T. Fibronectin in the formation and degradation of the pericellular matrix. Ciba Found Symp. 1985; 114:111-126.
11. Vaheri A, Salonen E-M. Fibronectin and regulation of proteolysis in cancer and tissue destruction. Proc Finn Dent Soc. 1988; 84:13-18.
12. Tervo T, Salonen E-M, Vaheri A, et al. Elevation of tear fluid plasmin in corneal disease. Acta Ophthalmol (Copenh). 1988; 66:393-396.
13. Berman MB, Kenyon K, Hayashi K, L'Hernault N. In: Cavanagh HD, ed. The Cornea: Transactions of the World Congress on the Cornea. New York: Raven Press; 1988: 35-43.
14. Kueppers F. Proteinase inhibitors in human tears. Biochim Biophys Acta. 1971; 229:845-849.
15. Berman MB, Barber JC, Talamo RC, Langley CE. Corneal ulceration and the serum antiproteases: I: α1-antitrypsin, Invest Ophthalmol. 1973; 12:759-770.
16. Rennert OM, Kaiser D, Sollberger H, Joller-Jemelka S. Anti-protease activity in tears and nasai secretions. Humangenetik. 1974; 23:73-77.
17. Zinn M, Ritzinger I. Der diagnostische Wert einer Alpha-1-Antitrypsinbestimmung in der Tränenflüssigkeit, Klin Monatsbl Augenheilkd. 1978; 173:221-225. In German.
18. Leib ML, Shuster J, Little JM, Lorenzétti DWC. The determination of alpha-2-macroglobulin in tears by laser nephelometry. ARVO Abstracts. Invest Ophthalmol Vis Sci. 1980; 21:201.
19. Andersson JA, Leopold IH. Antiproteolytic activities found in human tears. Ophthalmology. 1981; 88:82-84.
20. van Haeringen NJ. Clinical biochemistry of tears. Surv Ophthalmol. 1981; 26:84-96.
21. Prause JU. Serum antiproteases and polymorphonuclear leucocytes neutral collagenolytic proteases in the tear fluid of patients with corneal ulcers treated with n-butylicyano acid. Acta Ophthalmol 1983; 61:283-291.
22. Berta A, Vámosi P, Tözsér J. Eine neue Methode zur semiquantitativen Alpha-1-Antitrypsinbestimmung in der menschlichen Tränenflüssigkeit. Fortschr Ophthalmol. 1989;86:773-776. In German.
23. Prause JU. Cellular and biochemical mechanisms involved in the degradation and healing of the cornea. Acta Ophthalmol (Copenh). 1984; 1-40.
24. Kang J, Lemaire HG, Unterbeck A, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987; 325;733-736.
25. Kitaguchi N, Takahashi Y, Tokushima Y, Shiojiri S, Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 1988; 331:530-532.
26. Ponte P, Gonzalez-DeWhitt P, Schilling J, et al. A new A4 amyloid mRNA contains a domain homologous to serine proteinase inhibitors. Nature. 1988; 331:525-527.
27. Tanzi RE, McClatchey AI, Lamperti ED, Villa-Komaroff L, Gusella JF, Neve RL. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 1988; 331: 528-530.
28. Esch FS, Keim PS, Beattie EC, et al. Cleavage of amyloid β peptide during constitutive processing of its precursor. Science. 1990; 248:1122-1124.
29. van Setten G-B, Tervo T, Andersson R, Perheentupa J, Tarkkanen A. Plasmin and epidermal growth factor in the tear fluid of contact-lens wearers: Effect of wearing different types of contact lenses and association with clinical findings. Ophthalmic Res. 1990; 22:233-240.
30. Schägger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem. 1987; 166:368-379.
31. Ramabhadran TV, Gandy SE, GhisoJ, et al. Proteolytic processing of human amyloid β protein precursor in insect cells: Major carboxyl-terminal fragment is identical to its human counterpart. J Biol Chem. 1993; 268:2009-2012.
32. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987; 162:156-159.
33. Nilsson L, Mohammed AKH, Henriksson BG, Folkesson R, Winblad B, Bergström L. Environmental influence on somatostatin levels and gene expression in the rat brain. Brain Res. 1993;628:93-98.
34. Durnam DM, Palmiter RD. A practical approach for quantitating specific mRNAs by solution hybridisation. Anal Biochem. 1983; 131:385-393.
35. Johnston JA, Cowburn RF, Norgren S, et al. Increased β-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/ 671 mutation. FEBS Lett. 1994; 354:274-278.
36. Labarca C, Paigen K. A simple, rapid, and sensitive DNA assay procedure. Anal Biochem. 1980; 102:344-352.
37. Wunderlich D, Lee A, Fracasso RP, Mierz DV, Bayney RM, Ramabhadran TV. Use of recombinant fusion proteins for generation and rapid characterization of monoclonal antibodies: Application to the Kunitz domain of human β amyloid precursor protein. J Immunol Meth, 1992; 147:1-11.
38. Slunt HH, Thinakaran G, Von Koch C, Lo AC, Tanzi RE, Sisodia SS. Expression of a ubiquitous, cross-reactive homologue of the mouse β-amyloid precursor protein (APP). J Biol Chem. 1994; 269:2637-2644.
39. Buxbaum JD, Gandy SE, Cicchetti P, et al. Processing of Alzheimer β/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc Natl Acad Sci USA. 1990; 87:6003-6006.
40. Moir RD, Martins RN, Bush AI, et al. Human brain βA4 amyloid protein precursor of Alzheimer's disease: Purification and partial characterization. J Neurochem. 1992; 59:1490-1498.
41. Egeberg J, Jensen OA. The ultrastructure of the acini in the human lacrimal gland. Acta Ophthalmol. 1969; 47:400-410.
42. Kühnel W. Vergleichende histologiche, histochemiche und elektronenmikroskopische Untersuschungen an Tränendrüsen: VI: Menschliche Tränendrüse. Zeitschr Zellfosch. 1968; 89:552-557. In German
43. Nordstedt C, Näslund, J, Thyberg J, Messamore E, Gandy SE, Terenius L. Human neutrophil phagocytic granules contain a truncated soluble form of the Alzheimer β/A4 amyloid precursor protein (APP). J Biol Chem. 1994; 269:9805-9810.
44. Caporaso GL, Gandy SE, Buxbaum JD, Ramabhadran TV, Greengard P. Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc Natl Acad Sci USA. 1992; 89:3055-3059.
45. Selkoe DJ. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu Rev Cell Biol. 1994; 10:373-403.
46. Weidemann A, König G, Bunke D, et al. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell. 1989; 57:115-126.
47. Zirm M, Schmut O, Hoffmann H. Quantitative Bestimmung der Antiproteasen in der menschlichen Tränenflüssigkeit. Albrecht von Graefe's Arch Clin Exp Ophthalmol. 1976; 198:89-94. In German.
48. Sinha S, Dovey HF, Seubert P, et al. The protease inhibitory properties of the Alzheimer's β-amyloid precursor protein. J Biol Chem. 1990; 265:8983-8985.
49. Overly CC, Fritz LC, Lieberburg I, McConlogue L. The β-amyloid precursor protein is not processed by the regulated secretory pathway. Biochem Biophys Res Commun. 1991; 181:513-519.